InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Komjathy Andrew, Directeur Commercial. Officer active across 1 company, notably Astria Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €589. Activity tracked since 19 November 2021. The latest transaction was disclosed on 19 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Komjathy Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
10 股Common StockSEC:0000905148-26-000319:0
100 股@ US$6.695100.0% 占其流量Common StockSEC:0001104659-21-143035:0
标准退出：2022年2月17日 (T+90)
2 条申报中的 2 条
About Komjathy Andrew
Komjathy Andrew is the Chief Commercial Officer at Astria Therapeutics, Inc. He oversees commercial operations and contributes to the company's growth strategy.
